Drug Trial Radar · NCT00047749
Prialt (Ziconotide) In Severe Chronic Pain
Last checked: Nov 20, 2026Latest source record: Dec 14, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
220
Actual
Start
Aug 2002
Primary completion
Not stated
Study completion Jun 2003
Sponsor
- Lead sponsor
- Elan PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Oct 17, 2002
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to understand the effects of intrathecal ziconotide (an experimental pain medication) when the dose is slowly increased over a 3-week period in patients with severe chronic pain. During the weaning phase, the study will also gather information about switching from other intrathecal or IT medication (slowly pumped directly into the space around the spine) to other systemic pain medication (by mouth or through the skin using a patch). After being weaned off current IT medication, patients will be placed on IT ziconotide or placebo (non-active substance) as well as being allowed a stable dose of systemic pain medications. Patients who complete this study may be eligible for long-term ziconotide therapy via extension protocol ELN92045-352.
Conditions
- Pain
Interventions
Prialt (ziconotide)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
44 sites in 1 country. Site status is shown where the registry gives one.
Tennesee Valley Pain Consultants - Center For Pain Management
Huntsville, Alabama
The Pain Center
Northport, Alabama
Outcomes Research International
Tucson, Arizona
The RC Goodman Pain Institute: Clinical Research
Fort Smith, Arkansas
Hot Springs Mercy Pain Clinic
Hot Springs, Arkansas
Innovative Spine Care
Little Rock, Arkansas
Advanced Pain Medicine
Bakersfield, California
Advanced Pain Institute
Duarte, California
UCSD Medical Center, Thornton Hospital
La Jolla, California
Abaci and Massey Pain Center
Los Gatos, California
UCSF Pain Management Center
San Francisco, California
Pain Care Specialists
Colorado Springs, Colorado
Clinical Pharmacology Services, Inc.
Tampa, Florida
Georgia Medical Research Institute
Marietta, Georgia
Rush Presbyterian - St. Luke's Medical Center
Chicago, Illinois
University of Kentucky, Dept Anesthesiology
Lexington, Kentucky
Johns Hopkins Hospital, Division of Pain Management
Baltimore, Maryland
Arnold Pain Management
Boston, Massachusetts
Edina Medical Pain Center
Edina, Minnesota
Research Medical Center - Pain Institute
Kansas City, Missouri
Yellowstone Medical Center East
Billings, Montana
Huntington Center for Pain Treatment
Huntington, New York
Weill Medical College of Cornell University
New York, New York
Medical Pain Management of Central NY
Syracuse, New York
Center For Clinical Research
Winston-Salem, North Carolina
The Cleveland Clinic Foundation
Cleveland, Ohio
Pain Institute of Tulsa
Tulsa, Oklahoma
Pain Consultants of Oregon
Eugene, Oregon
Legacy Holladay Park Medical Center
Portland, Oregon
Penn State University Hospital
Hershey, Pennsylvania
Allegheny General Hospital
Pittsburgh, Pennsylvania
Advanced Clinical Concepts
Temple, Pennsylvania
Neurosurgery Foundation
Providence, Rhode Island
MUSC, Neurological Surgery
Charleston, South Carolina
Methodist Comprehensive Pain Institute
Memphis, Tennessee
Clinical Research Associates, Inc.
Nashville, Tennessee
University of Texas M.D. Anderson Cancer Center
Houston, Texas
Texas Tech University HSC
Lubbock, Texas
Consultants in Pain Research
San Antonio, Texas
Alpine Pain and Addiction Medicine
Salt Lake City, Utah
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.